Health

Scholars and practitioners debate whether and how to regulate off-label drug use.

Scholar argues that FDA approval should not save drug makers from state-law claims arising from off-label use.

Scholar recommends that regulators change food label laws to increase consumers’ access to plant-based meats.

UNOS may no longer retain sole control of the organ transplantation network.

Scholars assess global regulatory practices concerning human genome editing.

The FTC cracks down on improperly listed drug patents, challenging over 100 patent listings.

The COVID-19 response illustrates steps officials should take to ensure the effectiveness of vaccine mandates.

Scholars discuss the need for federal regulations to combat risks associated with technology in health care.

The Supreme Court must maintain pregnant people’s right to receive emergency medical care—including abortion.

Australia implements a new framework for regulating the medicinal use of psychedelic substances such as MDMA and psilocybin.

The government should lower regulatory hurdles impeding psilocybin assisted psychotherapy research.

Dispensaries could fill the regulatory void for psychedelics and promote public health.